• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱切除术后患者初始移行细胞复发模式。

Patterns of initial transitional cell recurrence in patients after cystectomy.

作者信息

Hassan J Matthew, Cookson Michael S, Smith Joseph A, Chang Sam S

机构信息

Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2765, USA.

出版信息

J Urol. 2006 Jun;175(6):2054-7. doi: 10.1016/S0022-5347(06)00323-5.

DOI:10.1016/S0022-5347(06)00323-5
PMID:16697802
Abstract

PURPOSE

We characterized initial relapse patterns in patients who underwent cystectomy for transitional cell carcinoma of the bladder at our institution.

MATERIALS AND METHODS

Between June 1995 and December 2001 a total of 417 patients underwent radical cystectomy for transitional cell carcinoma. Of the 399 patients treated with orthotopic diversion or incontinent cutaneous diversion, recurrent TCC developed in 86 (21.6%). We retrospectively examined this population to determine if any perioperative variables influenced the first site of disease recurrence.

RESULTS

Of the 86 patients in whom metastatic disease developed after cystectomy, the mean followup was 22.1 months. Mean time to disease recurrence was 15.1 months. Recurrence was most commonly initially in the pelvis (30.2%). Other common sites of first recurrence included the viscera (26.7%), the retroperitoneum (16.3%) and the skeletal system (16.3%). The site of first recurrence did not correlate significantly with gender, age, diversion type, pathological stage, nodal status, prostatic involvement or the presence of a positive surgical margin. Lymphovascular invasion was more prevalent in the pelvic recurrence group (62%) than in the retroperitoneal (36%), visceral (22%) or skeletal metastases (29%) groups (p = 0.03).

CONCLUSIONS

While the pelvis is the most common site of disease recurrence following radical cystectomy, TCC of the bladder recurs in an unpredictable pattern and aggressive surveillance is indicated. Patients with local pelvic recurrence had a higher percentage of lymphovascular invasion on cystectomy than the other recurrence site groups.

摘要

目的

我们对在我院接受膀胱移行细胞癌膀胱切除术患者的初始复发模式进行了特征分析。

材料与方法

1995年6月至2001年12月期间,共有417例患者因移行细胞癌接受了根治性膀胱切除术。在399例接受原位尿流改道或非可控性皮肤尿流改道治疗的患者中,86例(21.6%)出现了复发性移行细胞癌。我们对这一群体进行了回顾性研究,以确定是否有任何围手术期变量会影响疾病复发的首发部位。

结果

在86例膀胱切除术后发生转移性疾病的患者中,平均随访时间为22.1个月。疾病复发的平均时间为15.1个月。复发最常见于盆腔(30.2%)。其他常见的首次复发部位包括内脏(26.7%)、腹膜后(16.3%)和骨骼系统(16.3%)。首次复发部位与性别、年龄、尿流改道类型、病理分期、淋巴结状态、前列腺受累情况或手术切缘阳性与否均无显著相关性。盆腔复发组的淋巴管侵犯发生率(62%)高于腹膜后转移组(36%)、内脏转移组(22%)或骨骼转移组(29%)(p = 0.03)。

结论

虽然盆腔是根治性膀胱切除术后疾病复发最常见的部位,但膀胱移行细胞癌的复发模式难以预测,因此需要积极监测。与其他复发部位组相比,局部盆腔复发患者膀胱切除术后淋巴管侵犯的比例更高。

相似文献

1
Patterns of initial transitional cell recurrence in patients after cystectomy.膀胱切除术后患者初始移行细胞复发模式。
J Urol. 2006 Jun;175(6):2054-7. doi: 10.1016/S0022-5347(06)00323-5.
2
Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.膀胱切除及尿流改道术后尿道肿瘤复发:768例男性患者的临床及病理特征
J Urol. 2005 Apr;173(4):1163-8. doi: 10.1097/01.ju.0000149679.56884.0f.
3
Tumor recurrence in the remnant urothelium of females undergoing radical cystectomy for transitional cell carcinoma of the bladder: long-term results from a single center.接受根治性膀胱切除术治疗膀胱移行细胞癌的女性患者残余尿路上皮肿瘤复发:单中心长期结果
J Urol. 2006 Apr;175(4):1268-71; discussion 1271. doi: 10.1016/S0022-5347(05)00643-9.
4
Outcomes in patients with pathological carcinoma in situ only disease at radical cystectomy.仅患有病理原位癌的患者在根治性膀胱切除术后的结果。
J Urol. 2004 Sep;172(3):882-4. doi: 10.1097/01.ju.0000136294.15938.3d.
5
Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.根治性膀胱切除术后膀胱癌病理分期中的浅表性(pT2a)和深部(pT2b)肌肉浸润。
J Urol. 2006 Aug;176(2):493-8; discussion 498-9. doi: 10.1016/j.juro.2006.03.065.
6
The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.膀胱移行细胞癌患者根治性膀胱切除术后尿道复发的危险因素。
Urol Int. 2009;82(3):306-11. doi: 10.1159/000209363. Epub 2009 May 11.
7
Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.膀胱移行细胞癌根治性膀胱切除术后上尿路尿路上皮复发:1069例患者10年随访分析
J Urol. 2007 Jun;177(6):2088-94. doi: 10.1016/j.juro.2007.01.133.
8
Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.预测膀胱移行细胞癌根治性膀胱切除术后疾病复发的列线图。
J Urol. 2006 Oct;176(4 Pt 1):1354-61; discussion 1361-2. doi: 10.1016/j.juro.2006.06.025.
9
Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.膀胱移行细胞癌根治性膀胱切除术的疗效:来自膀胱癌研究联盟的当代系列研究
J Urol. 2006 Dec;176(6 Pt 1):2414-22; discussion 2422. doi: 10.1016/j.juro.2006.08.004.
10
Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.膀胱癌根治性膀胱切除术后软组织切缘阳性与癌症特异性生存
J Urol. 2007 Dec;178(6):2308-12; discussion 2313. doi: 10.1016/j.juro.2007.08.023. Epub 2007 Oct 22.

引用本文的文献

1
FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy.根治性膀胱切除术后用于定义肌层浸润性膀胱癌分子亚型的FOXA1基因表达
J Clin Med. 2020 Apr 2;9(4):994. doi: 10.3390/jcm9040994.
2
The Role of Adjuvant Radiation Therapy in Locally Advanced Bladder Cancer.辅助放疗在局部晚期膀胱癌中的作用
Bladder Cancer. 2018 Apr 26;4(2):205-213. doi: 10.3233/BLC-180163.
3
[Follow-up of bladder cancer : The right examinations at the right time].[膀胱癌的随访:在正确时间进行正确检查]
Urologe A. 2018 Jun;57(6):693-701. doi: 10.1007/s00120-018-0641-3.
4
The Rationale for Post-Operative Radiation in Localized Bladder Cancer.局限性膀胱癌术后放疗的理论依据
Bladder Cancer. 2017 Jan 27;3(1):19-30. doi: 10.3233/BLC-160081.
5
In-vitro cytocidal effect of water on bladder cancer cells: The potential role for intraperitoneal lavage during radical cystectomy.水对膀胱癌细胞的体外杀细胞作用:根治性膀胱切除术期间腹腔灌洗的潜在作用。
Can Urol Assoc J. 2015 Mar-Apr;9(3-4):E109-13. doi: 10.5489/cuaj.2435.
6
Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder.膀胱尿路上皮癌根治性膀胱切除术后局部区域复发的风险分层
World J Urol. 2015 Nov;33(11):1753-61. doi: 10.1007/s00345-015-1502-y. Epub 2015 Feb 8.
7
Survival benefit of adjuvant radiotherapy in stage III and IV bladder cancer: results of 170 patients.辅助放疗对Ⅲ期和Ⅳ期膀胱癌的生存益处:170例患者的结果
Cancer Manag Res. 2014 Nov 27;6:459-65. doi: 10.2147/CMAR.S69055. eCollection 2014.
8
Differences in the recurrence pattern after neoadjuvant chemotherapy compared to surgery alone in patients with muscle-invasive bladder cancer.肌层浸润性膀胱癌患者新辅助化疗后与单纯手术相比复发模式的差异。
Med Oncol. 2015 Jan;32(1):421. doi: 10.1007/s12032-014-0421-x. Epub 2014 Dec 4.
9
Multifactorial, site-specific recurrence models after radical cystectomy for urothelial carcinoma: external validation in a cohort of Korean patients.尿路上皮癌根治性膀胱切除术后多因素、特定部位复发模型:韩国患者队列中的外部验证
PLoS One. 2014 Jun 17;9(6):e100491. doi: 10.1371/journal.pone.0100491. eCollection 2014.
10
Clinicopathologic characteristics and overall survival in patients with bladder cancer involving the gastrointestinal tract.膀胱癌累及胃肠道患者的临床病理特征和总生存情况。
Virchows Arch. 2013 Dec;463(6):811-8. doi: 10.1007/s00428-013-1479-0. Epub 2013 Oct 4.